Semler Scientific
SMLR
About: Semler Scientific Inc is a United States based company that is engaged in providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. It focuses on developing, manufacturing, and marketing proprietary products and services that assist customers, including insurance plans, physicians, and risk assessment groups, in evaluating and treating chronic diseases. The company markets its vascular-testing product under the QuantaFlo brand, which is a four-minute in-office blood flow test. also invest in bitcoin and have adopted bitcoin as its treasury reserve asset. Company's healthcare technology solutions business is predominant operational focus, providing cash flows and enabling it to pursue bitcoin.
Employees: 79
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
123% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 26
100% more call options, than puts
Call options by funds: $68.4M | Put options by funds: $34.2M
52% more capital invested
Capital invested by funds: $239M [Q1] → $364M (+$125M) [Q2]
15.34% more ownership
Funds ownership: 68.84% [Q1] → 84.18% (+15.34%) [Q2]
14% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 22
0% more funds holding
Funds holding: 124 [Q1] → 124 (+0) [Q2]
50% less funds holding in top 10
Funds holding in top 10: 2 [Q1] → 1 (-1) [Q2]
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
3 analyst ratings
|
Cantor Fitzgerald
Brett Knoblauch
|
$60
|
Overweight
Maintained
|
6 Aug 2025 |
|
Maxim Group
Matt Galinko
|
$95
|
Buy
Initiated
|
9 Jul 2025 |
|
Benchmark
Mark Palmer
|
$101
|
Buy
Initiated
|
8 Jul 2025 |
Financial journalist opinion
Based on 62 articles about SMLR published over the past 30 days
